//Month Two Update

Month Two Update

Dear Friends,

Interest in the Alzheimer’s Germ Quest $1 Million Challenge Award continues to gain momentum. Here is a summary of our second month:

MEDIA ATTENTION:

Read the front-page newspaper article HERE.

Alzheimer's Germ Quest, GermanyAt left is Alzheimer’s Germ Quest CEO Dr. Leslie Norins being interviewed by a news crew who flew in on assignment from a German tv network. (air date TBA)

MEETINGS OF THE MINDS:

Team Alzheimer’s Germ Quest traveled to the 2018 National Institute of Health’s Alzheimer’s Research Summit and met several important leaders and scientists — all of whom encouraged our Challenge.

Maria Carrillo, Alzheimer's Association

(l-r) Dr. Leslie Norins, Dr. Maria Carrillo and Rainey Norins

Dr. Leslie Norins (r) with Dr. Eliezer Masliah, Director, Division of Neuroscience, NIA/NIH

 

 

 

 

 

 

 

Alzheimer's Germ Quest, Paul Auwaerter, Johns Hopkins Medical Center, Infectious Diseases Society of America

Dr. Paul Auwaerter, Professor of Medicine and Clinical Director of Infectious Diseases at Johns Hopkins Medical Center. He is also the current president of the Infectious Diseases Society of America. Dr. Norins is a Fellow Emeritus of IDSA

The team also visited Dr. Norins’ alma mater, Johns Hopkins, where they met several prominent physicians and respected researchers.

The team also met with Dr. Paul Auwaerter (pictured on the right), Professor of Medicine and Clinical Director of Infectious Diseases at Johns Hopkins Medical Center, and Dr. Constantine “Kostas” Lykestos, who directs the Johns Hopkins Memory and Alzheimer’s Treatment Center and is Associate Director of the Alzheimer’s Disease Research Center.

FROM THE MAILBAG:

We certainly do not disregard the possibility of an infectious etiology contributing to this condition.

Hugh Auchincloss, MD
Deputy Director
National Institute of Allergy and Infectious Disease, NIH

 

RESEARCH CONNECTIONS:

Dr. Keith Rubin (l) with Dr. Norins (r)

At left is Dr. Keith Rubin (l), CEO of ILiaD Biotechnologies, who visited the Alzheimer’s Germ Quest headquarters to discuss his concept of pertussis as a possible Alzheimer’s germ participant.

Dr. Tanzi (l) with Dr. Norins (r)

Later in the month, Dr. Norins met with Dr. Rudolph Tanzi (l), Vice-Chair of Neurology at Harvard Medical School and Massachusetts General Hospital. Dr. Tanzi is Chair of the Research Leadership Group for the Cure Alzheimer’s Fund, and is a prominent researcher in inflammation aspects of Alzheimer’s brain damage.

VISITING THE FRONTLINE:

The Alzheimer’s Germ Quest team also met a group of caregivers who work to provide activity services to those living with the disease, and respite to caregivers.

The Alzheimer’s Germ Quest team toured the Naples Senior Center. Pictured left is Dr. Leslie Norins speaking with Sheila Harris-Schutz (l), widow of Peter Schutz, former CEO of Porsche International, who was served by activities at Naples Senior Center. Also pictured is Dr. Jaclynn Faffer (r), President and CEO of the center.

SPREAD THE WORD:

Toward the end of the month, Dr. Norins presented the “germ” possibility to attendees at the Risk Assessment Forum’s national meeting, which included medical directors and lead underwriters at America’s top life insurance companies.

TOMORROW’S AMBITIONS:

 


The Alzheimer’s Germ Quest team will attend the AAIC-2018 Summit in Chicago, July 22-25. Please come to meet us there!

Together, we can keep the spotlight on defining the role of germs.

With continued appreciation,
Leslie C. Norins, MD, PhD
Founder and CEO
Alzheimer’s Germ Quest, Inc.

P.S. I’d appreciate your comments and suggestions. Email me personally at: leslie.norins@alzgerm.org

 

 

2018-04-13T13:04:57+00:00 April 4, 2018|News|